Information

888-383-0553

Description

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its total assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development. The fund is non-diversified.

Click to get the best stock tips daily for free!
ABOUT BIOSHARES BIOTECHNOLOGY CLINICAL TRIALS FUND
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its total assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead ...
GOLDEN STAR
Ticker Change Signal Date
IBN
$29.02
0.448% Feb 11
HCP
$34.11
0.733% Feb 11
VRNT
$26.02
0.92% Feb 11
BSY
$46.63
0.172% Feb 11
LFUS
$234.72
5.50% Feb 10

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE